2010-February Archives by Thread

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...

Starting: Wed Feb 3 01:53:01 2010
Ending: Fri Feb 26 15:20:16 2010
Messages: 73

• [Ip-health] Pharmaceuticals in Developing and Emerging Economies:   Chikosa. Banda
• [Ip-health] Huffington Post: Why a Gates Foundation Gift Was Not Enough for Haiti's Children   Ann-Marie Sevcsik
  • [Ip-health] Huffington Post: Why a Gates Foundation Gift Was Not Enough for Haiti's Children   Mike Gretes
    • [Ip-health] Huffington Post: Why a Gates Foundation Gift Was Not Enough for Haiti's Children   Ann-Marie Sevcsik
• [Ip-health] WIPO Symposium on the Evolution of the Regulatory Framework of Test Data   Thiru Balasubramaniam
• [Ip-health] WIPO SCP 14: Summary of the Chair   Thiru Balasubramaniam
• [Ip-health] DownToEarth.org- A bad example from the US   Terri - Louise Beswick
• [Ip-health] Bridges Weekly: Closed-Door Anti-Counterfeiting Talks Continue in Mexico   Thiru Balasubramaniam
• [Ip-health] Mobile phone technology and health impact measurement   Aidan Hollis
• [Ip-health] Wall Street Journal: China Issued Record Number of Patents in 2009   Thiru Balasubramaniam
• [Ip-health] PharmaTimes- EU "pushing" India over generics in "secret" trade talks   Terri - Louise Beswick
• [Ip-health] Collaborating Centers of Excellence Set to Combat Chronic Diseases in Developing Countries   Joana Ramos
• [Ip-health] Stan McCoy on ACTA in Financial Times   peter maybarduk
• [Ip-health] Patent examiner experience levels in the US   Heesob Nam
• [Ip-health] MSF op-ed in Huffington Post: Profound Health Impact for Small Change   James ARKINSTALL
• [Ip-health] Looking at some of PhRMA's grants to US organizations in 2008   Malini Aisola
• [Ip-health] Ecuador creates public pharmaceutical firm Enfarma   peter.maybarduk@essentialinformation.org
• [Ip-health] Colombia rejects =?iso-8859-1?Q?Abbott=92s_appeal_on_Kaletra_price_regulation;_accion_popu?= lar update   peter.maybarduk@essentialinformation.org
• [Ip-health] FT: Pfizer launches tiered-pricing in emerging markets   Suerie Moon
• [Ip-health] American Cancer Society Receives $7 Million From Gates Foundation to Tackle Tobacco Use in Africa   Joana Ramos
• [Ip-health] =?windows-1252?Q?Delhi_High_Court_Rejects_Bayer=92s_Appeal_for_Patent?= =?windows-1252?Q?_Linkage?=   prathibha siva
• [Ip-health] MSF: Indian Court gives boost to access to medicines as latest appeal by Bayer is rejected   James ARKINSTALL
• [Ip-health] Indian Court rejects Bayers appeal for patent linkage   Leena Menghaney
• [Ip-health] Mondaq- European Commission To Check Whether Patent Settlements Concluded Between Pharmaceutical Companies Infringe EU Antitrust Rules   Terri - Louise Beswick
• [Ip-health] IP-Watch: WTO Members To Consider Review Of TRIPS Public Health Amendment   Thiru Balasubramaniam
• [Ip-health] WTO informal meeting (Feb 12) regarding TRIPS public health amendment: the Canada/Rwanda case   Richard Elliott
• [Ip-health] China: Patent conditions amended for drugs   Joan-Hu-Yuanqiong
• [Ip-health] Billy Tauzin leaving PhRMA in June   Ben Krohmal
• [Ip-health] Wall Street Journal: Drug Makers Decry Indian Patent Law   thiru@keionline.org
• [Ip-health] MSF: approval of heat-stable ritonavir ends years of neglect by Abbott   James ARKINSTALL
• [Ip-health] Rethinking compulsory licensing for export: WTO members hold informal consultations on Paragraph 6 implementation   thiru@keionline.org
• [Ip-health] New Law Bill in Brazil aims to establish patent "linkage"   Francisco Viegas Neves da Silva
• [Ip-health] Health Reform in Limbo, PhRMA's Tauzin Quits   robert weissman
• [Ip-health] Detailed Recap of White House-PhRMA Deal   robert weissman
• [Ip-health] New Disc Paper on HIF Creation and Commitment   Aidan Hollis
• [Ip-health] Pharmabiz- Indian concern about proposed India-EU FTA clause on data exclusivity spreads to Europe   Terri - Louise Beswick
• [Ip-health] DNA India- India-EU FTA gets flak in Europe   Terri - Louise Beswick
• [Ip-health] Profit-led drug shortage exposed   Joana Ramos
• [Ip-health] LiveMint- Indian drug makers worried by East Africa's legal proposals   Terri - Louise Beswick
• [Ip-health] Reuters (India)- Europeans spend billions on fake medicines-survey   Terri - Louise Beswick
• [Ip-health] Drug Firms Apply Brand to Generics   Joana Ramos
• [Ip-health] PharmaTimes- One in five Europeans buying fake drugs - Pfizer survey   Terri - Louise Beswick
• [Ip-health] Dow Jones: Brazil Formalizes Retaliation Guidelines Against US Cotton   Thiru Balasubramaniam
• [Ip-health] Bloomberg: Brazil to Sanction U.S. on Goods, Intellectual Rights   Thiru Balasubramaniam
• [Ip-health] Biotech Marathon: Vaccines And Open Innovation, But Less IP?   Sophie Bloemen
• [Ip-health] Colombia beats Abbott: Kaletra prices to drop 2/3   peter.maybarduk@essentialinformation.org
• [Ip-health] Bridges Weekly: Brazil Set to Announce List of US Goods for Sanctions, Takes First Step to Cross-Retaliate   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Biotech Marathon: Vaccines And Open Innovation, But Less IP?   Thiru Balasubramaniam
• [Ip-health] UNITAID Civil Society Delegations communique - Board special session on Patent Pool - 5th February 2010   Jessica Hamer
• [Ip-health] SUNS: Members discuss implementation of TRIPS "Para 6" solution   Thiru Balasubramaniam
• [Ip-health] Explosion in Special 301 filings   Sean Flynn
• [Ip-health] KEI comments on U.S.T.R. Special 301   Malini Aisola
• [Ip-health] Access to Medicines Submission to USTR Special 301   Sean Flynn
• [Ip-health] Brazilian WG of Intellectual Property (GTPI/REBRIP) written comment on the USTR 2010 Special 301   Francisco Viegas Neves da Silva
• [Ip-health] Press release- Prioritise and protect Access to medicines in Central America   Terri - Louise Beswick
• [Ip-health] Vacancy Notice - Technical Writer - UNITAID, Patent Pool Initiative   UNITAID Medicines Patent Pool Initiative
• [Ip-health] US holds trade and investment talks with EAC   peter maybarduk
• [Ip-health] CPATH statement on 301 reports and Guatemala   Ellen Shaffer
• [Ip-health] Financial Times- White House tilts at barrier to cheap drugs   Terri - Louise Beswick
• [Ip-health] PharmaTimes- US, Israel resolve long-standing pharma battle   Terri - Louise Beswick
• [Ip-health] PharmiWeb- EAASM Calls for Enhanced Legislation Against Fake Drugs   Terri - Louise Beswick
• [Ip-health] Public Citizen's 301 submission on Ecuador's TRIPS-compliant licensing protocol   peter maybarduk
• [Ip-health] LiveMint- Indian exporters breathe easy as East African nations reject draft   Terri - Louise Beswick
• [Ip-health] Intellectual Property Enforcement Coordinator Requesting Public Comment   Sean Flynn
• [Ip-health] Course for NGOs on Securing Corporate Partnerships   Joana Ramos
  • [Ip-health] Course for NGOs on Securing Corporate Partnerships   Outterson, Michael Kevin
• [Ip-health] Lilly Is Fined By Mexico For Collusion   Joana Ramos
• [Ip-health] Express Scripts to Spin-off Rx Outreach to Create Nonprofit Offering Prescription Medicines   Joana Ramos
• [Ip-health] Parexel opens another early phase unit in South Africa   Joana Ramos
• [Ip-health] 653 Special 301 submissions   Sean Flynn
• [Ip-health] Next steps in Colombia: time for a compulsory license   peter maybarduk
• [Ip-health] PharmaTimes- Thai govt policies are killing local pharma, says industry   Terri - Louise Beswick
• [Ip-health] Job Posting: Vancouver BC - Neglected Diseases and Social Finance Postdoctoral Position   Mike Gretes

Last message date: Fri Feb 26 15:20:16 2010
Archived on: Fri Feb 26 15:20:17 2010

• Messages sorted by: [ subject ] [ author ] [ date ]
• More info on this list...